病原性に基づくCOVID-19の急性後遺症の治療戦略開発の必要性
Heng Wang1, Li Shen1, Song Xue1
1Department of Cardiovascular Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract:
The treatment of post-acute sequelae to COVID-19 (PASC) remains challenging. Defining PASC solely based on symptoms and disease duration in clinical trials can mask the potential for recovery in specific patient subgroups. A good design for future research requires a clear classification of various PASC according to different pathogenesis under the general diagnosis. Here, we discuss four key types of pathogenesis that should be recognized to determine the enrollment of PASC patients.
関連する概念動画
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Therapeutic Drug Monitoring: Overview and Classification
Classification of Titrimetric Analysis Based on Reaction Types
Titrations between an acid and a base lead to neutralization reactions that form...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.


